{"type":"profile","id":"profile=medica2026.3088194","exhSeoId":"7yz0b7GCR7yavJhLICgETg","name":"Auxiliis Biomarker Zrt.","email":"info@auxbiom.com","getInTouchEmail":"info@auxbiom.com","profileAddress":{"address":["Nagyváradi Utca 9.b."],"city":"Szentendre","zip":"2000","country":"Hungary","countryCode":"HU"},"phone":{"phone":"+36 70 3773847"},"links":[{"id":"link=WAM4EoROSru7wdPlN1J7UA","type":"link","link":"https://www.auxbiom.com","parentType":"profile","order":1,"visibleInLang":["en","de"]}],"media":[],"locations":[{"areaId":"17","area":"Hall 17","stand":"B45-49"}],"location":"Hall 17 / B45-49","locationIsVirtual":false,"events":[{"key":"medica2026","label":"MEDICA 2026"}],"eventIcons":[{"label":"MEDICA 2026","src":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png"}],"eventMap":"https://iahapla02.messe-duesseldorf.de/en/2dexgroundV2/medica2026/3088194.svg","areaMap":"https://iahapla02.messe-duesseldorf.de/en/3dhallV2/medica2026/17/3088194.svg","areaId":"17","mainExhibitor":{"id":"medica2026.3072462","label":"MEDICA START-UP PARK","exhSeoId":"Tk34kcAQTReUH7KJC70YZQ"},"premium":false,"exhIsLead":false,"logoUploadedByPubimport":false,"tags":[],"xtags":[],"socialMedia":[{"title":"LinkedIn","link":"https://www.linkedin.com/company/auxiliis-biomarker/","network":"linkedin","standardDomain":"https://www.linkedin.com/"}],"synonyms":[],"text":"<p>Auxiliis Biomarker Zrt., a Hungarian healthcare start-up makes the <strong>MMP-3 biomarker</strong> available in Europe for monitoring disease activity in rheumatoid arthritis. </p><p>&#160;</p><p>Monitoring disease activity in rheumatoid arthritis still relies largely on clinical scoring and on markers that are often non-specific. MMP-3 (matrix metalloproteinase-3) is a laboratory biomarker that reflects the degree of joint destruction and can support treatment decisions. Auxiliis Biomarker presents its MMP-3 assay, covering the clinical rationale, how results are interpreted in practice, the regulatory status and the platforms it runs on.</p><p>MMP-3 is CE marked and already available in Hungary at our laboratory partners. Our aim is to make it available throughout Europe.</p><p><br></p><p>We would be glad to meet distributors and laboratory partners at Medica 2026!</p>","pdfs":[],"tol":[],"categories":[{"id":"prod=medica2026.01.02.01","label":"Clinical chemistry & immunoassays","catalogIndex":"01.02.01","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=7IvVrJ25TRWk4hi13uhgvA","label":"MMP-3 biomarker: Key to understanding, diagnosing and treating rheumatoid arthritis."}],"hierarchy":[{"id":"01","label":"Clinical Diagnostics & Therapeutic Technologies"},{"id":"01.02","label":"Laboratory, IVD & Diagnostics"},{"id":"01.02.01","label":"Clinical chemistry & immunoassays"}]}],"write":false,"lastModified":"2026-11-05T14:25:09Z","tagsAreEditable":false,"xtagsAreEditable":false,"isGetInTouchAllowed":false}